内化
LNCaP公司
内吞作用
内体
抗体
单克隆抗体
免疫电镜
前列腺癌
抗原
细胞生物学
表位
化学
生物
细胞
癌症
免疫学
生物化学
遗传学
作者
He Liu,A K Rajasekaran,P. Moy,Yan Xia,Sae Kim,Vincent Navarro,R Rahmati,Neil H. Bander
出处
期刊:PubMed
日期:1998-09-15
卷期号:58 (18): 4055-60
被引量:419
摘要
Prostate-specific membrane antigen (PSMA) is a cell surface glycoprotein expressed predominantly by prostate cancer cells. We have characterized four monoclonal antibodies that bind to the extracellular domain of PSMA (Liu et al., Cancer Res., 57: 3629-3634, 1997). Here we report that viable LNCaP cells internalize these antibodies. Laser scanning confocal microscopy reveals that the internalized antibodies accumulate in endosomes, and immunoelectron microscopy reveals that endocytosis of the PSMA-antibody complex occurs via clathrin-coated pits. In addition, a quantitative cell surface biotinylation assay demonstrates that PSMA is constitutively endocytosed in LNCaP cells and that anti-PSMA antibodies increase the rate of internalization of PSMA. These studies suggest that PSMA might function as a receptor mediating the internalization of a putative ligand. The availability of prostate-specific internalizing antibodies should aid the development of novel therapeutic methods to target the delivery of toxins, drugs, or short-range isotopes specifically to the interior of prostate cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI